The demand for CRAs is a challenging and ongoing problem for the clinical research industry. This increasing demand has been precipitated by a number of factors, including the rising scale and complexities of clinical trials, heightened regulatory scrutiny, and the significant increase in competition for trial patients in certain geographies. At the same time, there is a “talent drought” – a lack of qualified talent to fill these roles and meet the growing demand.
In this white paper, you’ll learn more about how PRA is meeting the demands of the dynamic clinical research industry by supplying the next generation of competent, technologically savvy CRAs.
Key takeaways include:
- Understanding experience versus competence in CRA performance
- Awareness of PRA’s CRA Bridge Program, an industry-leading, comprehensive training program that provides core CRA foundation training, practical application, and comprehensive mentoring and coaching
- Bridge CRAs often perform at the same level or higher than CRAs with many more years of experience across a variety of measured CRA skill sets
HI*PRA: The Values That Guide Us
HI*PRA is a beacon that collectively signals the meaning of both PRA’s culture and work. It’s a coalescence of values that guide each and every one…
PRA Named Among America’s Best Large Companies
PRA Health Sciences is enormously proud to be named one of America’s Best Large Employers for 2021 by global media company Forbes. This recognition…
This page has been redirected to ICON plc
PRA Health Sciences Investor Relations